We are evaluating a new medication for safety and effectiveness in healthy individuals and those with autosomal dominant polycystic kidney disease. This study aims to understand how the drug works in different groups of people.
Health conditions and diseases that the clinical trial is designed to study and treat.
Polycystic Kidney Disease (ADPKD) is a genetic disorder characterized by the formation of multiple cysts in the kidneys, leading to kidney enlargement and potential kidney failure. It is inherited in an autosomal dominant pattern, meaning only one copy of the mutated gene is needed to develop the condition.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
